(06160) – Corporate News
-
BeiGene (BGNE) Receives FDA Approval for TEVIMBRA for the Treatment of Advanced or Metastatic ESCC After Prior Chemotherapy
-
BeiGene (BGNE) Receives Positive CHMP Opinion for BRUKINSA in Relapsed or Refractory Follicular Lymphoma
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to 06160 Stock Lookup